We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.8B
AUM Growth
+$485M
Cap. Flow
-$250M
Cap. Flow %
-2.12%
Top 10 Hldgs %
39.85%
Holding
1,230
New
34
Increased
603
Reduced
253
Closed
43

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$211M
2
SPG icon
Simon Property Group
SPG
+$189M
3
OHI icon
Omega Healthcare
OHI
+$130M
4
MPT
Medical Properties Trust
MPT
+$128M
5
CUZ icon
Cousins Properties
CUZ
+$104M

Top Sells

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$190M
2
EXR icon
Extra Space Storage
EXR
+$167M
3
EQIX icon
Equinix
EQIX
+$109M
4
GLPI icon
Gaming and Leisure Properties
GLPI
+$106M
5
ELS icon
Equity Lifestyle Properties
ELS
+$103M

Sector Composition

Rank Sector Weight
1 Real Estate 73.1%
2 Technology 4.03%
3 Financials 3.16%
4 Industrials 2.98%
5 Healthcare 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
1101
Collegium Pharmaceutical
COLL
$1.14B
$2K ﹤0.01%
180
– –
CRBP icon
1102
Corbus Pharmaceuticals
CRBP
$170M
$2K ﹤0.01%
14
– –
CRNX icon
1103
Crinetics Pharmaceuticals
CRNX
$8.86B
$2K ﹤0.01%
153
– –
CTMX icon
1104
CytomX Therapeutics
CTMX
$705M
$2K ﹤0.01%
285
– –
DBVT
1105
DBV Technologies
DBVT
$807M
$2K ﹤0.01%
19
+6
+46% +$572
DNTH icon
1106
Dianthus Therapeutics
DNTH
$5.68B
$2K ﹤0.01%
14
– –
LXRX icon
1107
Lexicon Pharmaceuticals
LXRX
$1.02B
$2K ﹤0.01%
583
– –
MCRB icon
1108
Seres Therapeutics
MCRB
$48M
$2K ﹤0.01%
22
+11
+100% +$727
MNOV icon
1109
MediciNova
MNOV
$65M
$2K ﹤0.01%
268
– –
NERV icon
1110
Minerva Neurosciences
NERV
$188M
$2K ﹤0.01%
27
– –
OPTN
1111
DELISTED
OptiNose
OPTN
$2K ﹤0.01%
18
– –
PRTA icon
1112
Prothena Corp
PRTA
$458M
$2K ﹤0.01%
212
– –
RIGL icon
1113
Rigel Pharmaceuticals
RIGL
$680M
$2K ﹤0.01%
81
– –
UBX
1114
DELISTED
Unity Biotechnology
UBX
$2K ﹤0.01%
27
– –
XERS icon
1115
Xeris Biopharma Holdings
XERS
$1.44B
$2K ﹤0.01%
170
– –
ITCI
1116
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2K ﹤0.01%
302
– –
CBAY
1117
DELISTED
Cymabay Therapeutics
CBAY
$2K ﹤0.01%
378
– –
IMGN
1118
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
955
+224
+31% +$595
TWTR
1119
PUT
DELISTED
Twitter, Inc.
TWTR
$2K ﹤0.01%
2,751
-500
-15% -$20.4K
CCXI
1120
DELISTED
ChemoCentryx, Inc.
CCXI
$2K ﹤0.01%
365
– –
AMAG
1121
DELISTED
AMAG Pharmaceuticals
AMAG
$2K ﹤0.01%
195
– –
FTSV
1122
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$2K ﹤0.01%
269
+71
+36% +$583
DERM
1123
DELISTED
Dermira, Inc.
DERM
$2K ﹤0.01%
347
+78
+29% +$651
PDLI
1124
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
853
– –
AQST icon
1125
Aquestive Therapeutics
AQST
$462M
$1K ﹤0.01%
163
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2019 Portfolio in Review

As of Q3 2019, Daiwa Securities Group held 1,230 positions worth $11.8B, up 4.3% from $11.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Daiwa Securities Group's Q3 2019 filing shows 34 new, 603 increased, 253 reduced and 43 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M. The largest sale was Public Storage, an estimated $190M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 72% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M.
  • Daiwa Securities Group added most to Realty Income in Q3 2019, an estimated $211M increase.
  • Daiwa Securities Group's biggest Q3 2019 reduction was Public Storage, cutting an estimated $190M.
  • Daiwa Securities Group fully exited Coupa Software Incorporated in Q3 2019, selling an estimated $4.17M.
  • Daiwa Securities Group's ten largest holdings make up 40% of its $11.8B portfolio in Q3 2019.
  • Daiwa Securities Group opened 34 new positions and closed 43 in Q3 2019.
  • Daiwa Securities Group's portfolio value rose 4.3% quarter-over-quarter to $11.8B.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.